A phase 2 cooperative group adjuvant trial using a biomarker‐based decision algorithm in patients with stage I non‐small cell lung cancer (SWOG‐0720, NCT00792701)-Reference-Cited by-同舟云学术

A phase 2 cooperative group adjuvant trial using a biomarker‐based decision algorithm in patients with stage I non‐small cell lung cancer (SWOG‐0720, NCT00792701)

Published:2014-04-18 Issue:15 Volume:120 Page:2343-2351
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Bepler Gerold¹,Zinner Ralph G.²,Moon James³,Calhoun Royce⁴,Kernstine Kemp⁵,Williams Charles C.⁶,Mack Philip C.⁴,Oliveira Vasco¹,Zheng Zhong⁶,Stella Philip J.⁷,Redman Mary W.²,Gandara David R.⁴

Affiliation:

1. Karmanos Cancer InstituteDetroit Michigan

2. The University of Texas MD Anderson Cancer CenterHouston Texas

3. SWOG Statistical CenterSeattle Washington

4. University of California at DavisSacramento California

5. City of HopeDuarte California

6. H. Lee Moffitt Cancer CenterTampa Florida

7. Michigan Cancer Research ConsortiumCommunity Clinical Oncology ProgramAnn Arbor Michigan

Funder

National Cancer Institute

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.28714

Reference32 articles.

1. Cisplatin-Based Adjuvant Chemotherapy in Patients with Completely Resected Non–Small-Cell Lung Cancer

2. Vinorelbine plus Cisplatin vs. Observation in Resected Non–Small-Cell Lung Cancer

3. Randomized clinical trial of adjuvant chemotherapy with paclitaxel and carboplatin following resection in stage IB non‐small‐cell lung cancer: report of the Cancer and Leukemia Group B protocol 9633 [abstract];Strauss GM;Proc Am Soc Clin Oncol.,2004

4. Adjuvant Paclitaxel Plus Carboplatin Compared With Observation in Stage IB Non–Small-Cell Lung Cancer: CALGB 9633 With the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups

5. Messenger RNA levels of XPAC and ERCC1 in ovarian cancer tissue correlate with response to platinum-based chemotherapy.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. International Tailored Chemotherapy Adjuvant (ITACA) trial, a phase III multicenter randomized trial comparing adjuvant pharmacogenomic-driven chemotherapy versus standard adjuvant chemotherapy in completely resected stage II-IIIA non-small-cell lung cancer;Annals of Oncology;2022-01

2. Adjuvant Systemic Therapy and Adjuvant Radiation Therapy for Stage I to IIIA Completely Resected Non–Small-Cell Lung Cancers: American Society of Clinical Oncology/Cancer Care Ontario Clinical Practice Guideline Update;Journal of Clinical Oncology;2017-09-01

3. Effects of p38MAPK-mediated excision repair cross-complementation 1 expression on prognosis of patients with non-small cell lung cancer;Oncology Letters;2017-07-21

4. Predictors of chemotherapy efficacy in non-small-cell lung cancer: a challenging landscape;Annals of Oncology;2016-11

5. Targeted therapy for localized non-small-cell lung cancer: a review;OncoTargets and Therapy;2016-07